Use of Molecular Imaging to Differentiate Neuroendocrine Tumors from Other Synchronous Primary Cancers: A Case Series Abstract #761

Introduction: Approximately 22% of neuroendocrine tumors (NET) co-exist with other cancers.
Aim(s): To identify the role of combination of molecular imaging studies for detection of, synchronous to NETs, common cancers and/or differentiate the origin of metastatic tumor lesions.
Materials and methods: Seven patients with NETs and other primaries, histologically proven, were included and had cross-sectional imaging, 68Gallium (Ga) -DOTATATE and 2-fluoro-2-deoxy-D-glucose (FDG) PET studies.
Conference: 10th Annual ENETS Conference (2013)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: DR Vincent Cheung
Keywords: NET, synchronous, PET, Gallium, FDG

To read results and conclusion, please login ...

Further abstracts you may be interested in

#758 Cardiac Metastases in Neuroendocrine Tumors- Diagnosis, Management and Outcomes
Introduction: Common areas of metastases in neuroendocrine tumors (NET) include liver, lymph nodes and bone. Limited data are available for cardiac metastases (CM).
Conference: 10th Annual ENETS Conference (2013)
Category: Epidemiology/Natural history/Prognosis - Descriptive epidemiology
Presenting Author: DR Vincent Cheung
#768 Long-Term Haematological and Renal Toxicity of 90Yttrium-DOTA-Octreotate in the Treatment of Advanced Neuroendocrine Tumors(NETs)
Introduction: Peptide receptor radiation therapy (PRRT) is an established treatment for advanced NETs. Renal/haematological toxicity are recognised adverse effects.
Conference: 10th Annual ENETS Conference (2013)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: DR VINCENT Cheung
#863 Assessment of Neuroendocrine Tumors' Heterogeneity with Combination of Molecular Imaging Studies
Introduction: Neuroendocrine tumors (NET) are heterogeneous neoplasms. The choice of the appropriate molecular imaging study for assessment of disease extent usually depends on tumor grade.
Conference: 11th Annual ENETS Conference (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: MD Roberta E Rossi
#887 Detection Limitation of Occult NET Using Gallium-68 Dotatoc Scan Plus FDG PET
Introduction: The modalities detection of gastroenteropancreatic neuroendocrine tumors (GEP-NET) includes sonogram, abdominal CT and MRI, but the detection rate is limited. Iodium-111 Octreotide scan is another choice. Ga-68 Dotatoc scan is very rapid and more sensitive than Octreoscan. The Ga-68 Dotatoc scan plus FDG-PET is useful for detecting active NETs.
Conference: 11th Annual ENETS Conference (2014)
Category: Imaging (radiology, nuclear medicine, endoscopy)
Presenting Author: Professor Tsann Long Hwang
Authors: Chen S H, Yen C C, Hwang T L, ...
#1134 Role of Cytoreductive Surgery (CRS) and Intraoperative Hyperthermicintraperitoneal Chemotherapy (HIPEC) for High Grade Neuroendocrine Tumour
Introduction: Managing patients with omental and peritoneal Nueroendocrine tumour is challenging.
Conference: 12th Annual ENETS Conference (2015)
Category: Clinical cases/reports
Presenting Author: Dr Mehmet Yalchin
Keywords: CRS HIPEC NET